TNYA [NASD]
Tenaya Therapeutics, Inc.
Index- P/E- EPS (ttm)-2.81 Insider Own0.30% Shs Outstand63.99M Perf Week19.08%
Market Cap196.67M Forward P/E- EPS next Y-2.59 Insider Trans- Shs Float60.93M Perf Month92.57%
Income-116.30M PEG- EPS next Q-0.65 Inst Own55.70% Short Float / Ratio1.41% / 2.70 Perf Quarter27.17%
Sales- P/S- EPS this Y-320.00% Inst Trans-7.60% Short Interest0.86M Perf Half Y-29.35%
Book/sh4.75 P/B0.71 EPS next Y8.80% ROA-43.20% Target Price24.00 Perf Year-64.82%
Cash/sh2.56 P/C1.32 EPS next 5Y- ROE-49.10% 52W Range1.64 - 16.17 Perf YTD67.66%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-79.16% Beta-
Dividend %- Quick Ratio8.90 Sales past 5Y- Gross Margin- 52W Low105.49% ATR0.27
Employees140 Current Ratio8.90 Sales Q/Q- Oper. Margin- RSI (14)73.98 Volatility11.93% 11.06%
OptionableYes Debt/Eq0.00 EPS Q/Q-9.30% Profit Margin- Rel Volume0.85 Prev Close3.42
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume317.87K Price3.37
Recom1.90 SMA2037.86% SMA5042.26% SMA200-25.51% Volume270,281 Change-1.46%
Jun-15-22Initiated H.C. Wainwright Buy $25
Jan-26-23 12:00PM
Jan-09-23 07:00AM
Dec-21-22 06:12AM
Dec-07-22 04:30PM
Dec-02-22 06:36PM
08:30AM Loading…
Nov-28-22 08:30AM
Nov-24-22 05:54AM
Nov-23-22 09:00AM
Nov-21-22 05:45PM
Nov-17-22 12:39AM
Nov-16-22 04:01PM
Nov-10-22 04:05PM
Nov-04-22 08:00AM
Oct-14-22 06:12AM
Oct-04-22 08:30AM
08:00AM Loading…
Sep-29-22 08:00AM
07:45AM
Sep-26-22 09:21AM
Sep-15-22 09:39AM
Sep-06-22 04:05PM
08:00AM
Aug-16-22 09:55AM
Aug-10-22 04:01PM
Jul-06-22 02:00PM
Jun-16-22 08:00AM
May-20-22 08:30AM
May-11-22 04:09PM
May-07-22 09:38AM
May-03-22 08:00AM
Apr-28-22 08:00AM
08:30AM Loading…
Mar-24-22 08:30AM
Mar-23-22 04:05PM
Feb-08-22 12:01PM
Feb-04-22 01:03PM
Jan-31-22 08:00AM
Jan-10-22 08:00AM
Dec-23-21 12:38PM
Dec-22-21 04:05PM
Dec-17-21 10:06AM
Nov-22-21 08:00AM
Nov-19-21 08:00AM
Nov-10-21 04:05PM
Nov-05-21 08:36PM
03:30AM
Nov-03-21 03:41PM
Oct-12-21 06:05PM
Oct-08-21 12:42PM
Oct-04-21 10:54AM
Sep-30-21 06:02PM
Sep-08-21 04:00PM
Aug-31-21 08:00AM
Aug-03-21 04:05PM
Jul-30-21 05:28PM
Jul-29-21 11:46PM
Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hypertrophic cardiomyopathy (gHCM) caused by haploinsufficient myosin binding protein C3 (MYBPC3) gene mutations; and TN-301, a small molecule inhibitor of histone deacetylase 6 (HDAC6i) for use in heart failure with preserved ejection fraction (HFpEF) and genetic dilated cardiomyopathy (gDCM). It is also developing TN-401, an AAV-based gene therapy that addresses genetic arrhythmogenic right ventricular cardiomyopathy (gARVC) caused by plakophilin 2 (PKP2) gene mutations; an AAV-based gene therapy designed to deliver the dwarf open reading frame (DWORF) gene in the heart for DCM; and Reprogramming program, an AAV-based approach for cardiac regeneration to replace heart cells lost in patients experiencing heart failure due to prior myocardial infarction. The company was incorporated in 2016 and is headquartered in South San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
COLUMN GROUP III GP, LP10% OwnerJan 19Buy2.5069,739174,2019,870,274Jan 23 04:25 PM
GOEDDEL DAVID VDirectorJan 19Buy2.5069,739174,2019,870,274Jan 23 04:21 PM
COLUMN GROUP III GP, LP10% OwnerJan 18Buy2.52135,688341,4329,800,535Jan 19 04:18 PM
GOEDDEL DAVID VDirectorJan 18Buy2.52135,688341,4329,800,535Jan 19 04:13 PM
COLUMN GROUP III GP, LP10% OwnerJan 17Buy2.4949,463123,3959,664,847Jan 19 04:18 PM
GOEDDEL DAVID VDirectorJan 17Buy2.4949,463123,3959,664,847Jan 19 04:13 PM
Srivastava DeepakDirectorNov 21Buy2.60230,769599,999372,435Dec 09 07:59 PM
COLUMN GROUP III GP, LP10% OwnerNov 21Buy2.609,615,38424,999,9989,615,384Nov 23 04:12 PM
GOEDDEL DAVID VDirectorNov 21Buy2.609,615,38424,999,9989,615,384Nov 23 04:11 PM
Casdin EliDirectorNov 17Buy2.602,492,0426,479,3096,078,860Nov 25 07:05 PM
Hoey TimothyChief Scientific OfficerApr 26Sale10.131,35313,706198,646Apr 28 07:57 PM